本文選題：經(jīng)皮冠狀動脈介入　切入點：焦慮　出處：《南京中醫(yī)藥大學學報》2017年03期 　論文類型：期刊論文

【摘要】：目的評價益心舒膠囊對經(jīng)皮冠狀動脈介入(PCI)術后患者的焦慮、抑郁情緒和生活質量改善的有效性和安全性。方法采用Zung焦慮自評量表(SAS)、抑郁自評量表(SDS)篩選出59例并發(fā)焦慮、抑郁情緒的患者,按照2∶1的比例隨機分為治療組(40例)和對照組(19例),2組均常規(guī)給以冠心病二級預防治療,治療組加用益心舒膠囊;分別在入院、第1月、第2月、第3月進行HRSD、HAMA、SF-36評分。結果 2組焦慮、抑郁情緒均有明顯改善,與治療前比,HRSD、HAMA評分P0.05~0.01,治療組優(yōu)于對照組(P0.05~0.01);治療組SF-36的生理功能、生理職能、軀體疼痛和一般健康的評分與治療前比,P0.05~0.01,對照組生理功能、軀體疼痛、一般健康與治療前比較,P0.05~0.01,治療組優(yōu)于對照組(P0.05~0.01)。結論益心舒膠囊可緩解PCI術后患者焦慮、抑郁情緒,改善其生活質量,無嚴重的不良反應。
[Abstract]:Objective to evaluate the efficacy and safety of Yixinshu capsule in improving anxiety, depression and quality of life (QOL) after percutaneous coronary intervention (PCI). Patients with depression were randomly divided into treatment group (n = 40) and control group (n = 19) according to the ratio of 2: 1. The patients in the treatment group were treated with secondary prophylaxis of coronary heart disease and the treatment group were treated with Yixinshu capsule, respectively, on admission, January, February, respectively. Results the scores of anxiety and depression were significantly improved in both groups, and compared with those before treatment, the scores of Hama in the treatment group were better than those in the control group (P 0.05 鹵0.01), and the physiological function and function of SF-36 in the treatment group were better than that in the control group. The scores of somatic pain and general health were higher than that of P0.05P0.01before treatment, the physiological function, somatic pain and general health of the control group were better than that of the control group (P0.05P0.05P0.011.Conclusion Yixinshu capsule can relieve anxiety and depression in patients after PCI. Improve their quality of life, no serious adverse reactions.
【作者單位】： 嘉善縣第一人民醫(yī)院急診內科;浙江大學醫(yī)學院附屬第二醫(yī)院;
【基金】：“重大新藥創(chuàng)制”科技重大專項(2014ZX09201021009)
【分類號】：R54

【相似文獻】

相關期刊論文 前4條

1 牛愛原;田琪;;益心舒膠囊聯(lián)合低分子肝素鈣治療慢性肺源性心臟病急性加重期患者的臨床觀察[J];中國醫(yī)院用藥評價與分析;2014年08期

2 劉漢桃;劉新建;魯威;;益心舒膠囊聯(lián)合美托洛爾治療室性早搏的臨床觀察[J];中國醫(yī)院用藥評價與分析;2014年07期

3 邰秀洋;;益心舒膠囊與富馬酸比索洛爾聯(lián)合治療肥厚性心肌病的臨床觀察[J];臨床合理用藥雜志;2014年21期

4 ;[J];;年期

，

本文編號：1641478